Team: Vanderbilt University, Tennessee, U.S.
Review: American Association for Cancer Research
The researchers studied 338 cases of cancer and 451 healthy women, and measured blood levels of CRP, protein used as a marker of inflammation. The result is that the quartile of highest values had a 2.5 times higher risk of having cancer colon than the lowest quartile.
A marker exists for colorectal cancer, but it is not used in the diagnosis, because its specificity is not perfect, it is the ACE protein. The specificity of CRP is obviously not better because it is increased in many circumstances.
http://www.rechercheclinique.com/informations/?id=1219&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed% 3A + +% Recherchecliniquecom 28RechercheClinique.com% 29 & utm_content = Google + Reader
0 comments:
Post a Comment